We examine how R&D portfolios of drug pipelines affect pharmaceutical licensing, controlling firm size, diversity, and … pharmaceutical companies between 1997 and 2007. We pay special attention to stage-specific licensing by dividing the innovation … significantly affect stage-specific licensing. Particularly, the state of drug pipelines is leveled off by license-outs at the early …

increase incentives to invest in R&D as they increase profits from licensing. However, incentives to invest of inventors who …

produce an environmentally friendly good through R&D or licensing obtained from the domestic firm. However, this does not … licensing, governments may intervene to shift the rent from the domestic firm. In certain circumstances, the shifted rent could … exceed the amount paid by the foreign firm for licensing. …

an intellectual property clearinghouse that reduces transaction costs associated with licensing. We show that this causes …

licensing. Using firm level data, it is shown empirically that the productivity of multinational firms differs significantly …